New hope for chemo-resistant breast cancer: radiotherapy plus immunotherapy
NCT ID NCT07457359
First seen Mar 26, 2026 · Last updated May 20, 2026 · Updated 5 times
Summary
This study is for people with triple-negative breast cancer whose tumors did not shrink after standard chemotherapy. The goal is to see if adding a short course of high-precision radiation followed by an immunotherapy drug (toripalimab) and more chemo can make the cancer disappear before surgery. About 18 participants will receive this treatment and be monitored for safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TNBC, TRIPLE NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Department of Radiation Oncology，the Second Affiliated Hospital of Zhejiang University School of Medicine, hangzhou, zhejiang
RECRUITINGHangzhou, China
Conditions
Explore the condition pages connected to this study.